Just a few more days to apply for the Bridge Program 2025! If you're a mid-career drug development or biotech professional looking to expand your commercialisation knowledge and networks, now is your chance to join of the country's most significant biotech professional networks! Applications close this Sunday 👉9 February👈 Access the course flyer: https://lnkd.in/gkHv4VpZ Learn more and apply: https://lnkd.in/gCkdvDh The Bridge Program is a year-long training program on the scientific, legal, financial, clinical, regulatory and reimbursement elements of pharmaceutical commercialisation. The program is administered by QUT and supported by our industry leading partners: AbbVie | Amgen | The Australian National University (ANU) | AstraZeneca | Biodesign Australia | CSIRO | Moderna | Pfizer | Roche | UNSW | The University of Western Australia 📓 Access interactive online learning materials at your own pace from anywhere around Australia. 🤝 Connect with industry leaders in the Australian biotech ecosystem. Network with peers at events including the three-day Symposium. 👋 Join an alumni community of over 900 industry professionals. ⭐ Learn from the experts through our seminar series, presented by some of the biggest names in the business. 💡 Pitch your ideas and receive real-world feedback from industry experts in our pitch competition. Winners receive a funded industry immersion experience. QUT (Queensland University of Technology) | QUT Centre for Genomics and Personalised Health #BioTech #commercialisation #training #industry #professionaldevelopment
The Bridge Program
Pharmaceutical Manufacturing
Brisbane, QLD 2,502 followers
Transferring skills on the commercialisation of pharmaceutical research.
About us
The Bridge Program is convened and administered by Queensland University of Technology and involves a consortium of 15 pharmaceutical companies, universities and industry associations with the aim to boost the commercial outputs of Australian pharmaceutical research, by improving the quality and quantity of commercial deals that arise from Australia’s pharmaceutical research sector. As part of the MTPConnect Project Fund Program, The Bridge Program has been awarded industry matched funding to deliver an exciting education program that will provide the necessary training to enable successful commercialisation of Australian pharmaceutical research. Launched in June 2017, the program selects 100 participants annually from across Australia to take part in face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement disciplines that contribute to research translation and the commercialisation of medicines. Program participants will also benefit from direct exposure to networking opportunities with top pharmaceutical companies operating globally. The Bridge Program is unique in its integration into venture capital and global pharmaceutical networks and its ability to share specific, detailed and practical know-how that will assist researchers and entrepreneurs to improve the quality and quantity of leads that they could offer for development, and to accelerate the process of commercialisation. The Bridge Program is specifically set up as a national, sector-wide program that will benefit a large number of participants and their organisations, particularly those from the SME sector. The program will not only benefit trainees, it will also improve the planning and execution of research & development in their organisations, and the networking opportunities available to them. This will ultimately deliver more advanced and commercially viable leads, better deal opportunities, and higher returns from Australian research.
- Website
-
https://research.qut.edu.au/bridge/
External link for The Bridge Program
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Brisbane, QLD
- Type
- Partnership
- Founded
- 2017
- Specialties
- Pharmaceutical, Biotech, Commercialisation, Innovation, entrepreneurship, research, medical, professional development, mid-career research, health, and medical research
Locations
-
Primary
Kelvin Grove
Brisbane, QLD 4105, AU
Employees at The Bridge Program
-
Kevin Pfleger
Director, Biomedical and Health Innovation at The University of Western Australia and WA Life Sciences Innovation Hub
-
Kay Myo Min
Research Associate | Project manager
-
Lyn Griffiths
Director - Centre for Genomics and Personalised Health at QUT (Queensland University of Technology)
-
Jasmine Kaur, PhD
Research Fellow, Peripheral Nerve Injury (PNI), Spinal Cord Injury (SCI), MHIQ | Global Talent Visa Recipient, Health Industries | Biotechnologist |…
Updates
-
⭐Join one of the country’s most significant biotech professional networks!⭐ The Bridge Program has extended its application deadline to 👉9 February👈 Access the course flyer: https://lnkd.in/gkHv4VpZ Learn more and apply: https://lnkd.in/gCkdvDh The Bridge Program is a year-long training program on the scientific, legal, financial, clinical, regulatory and reimbursement elements of pharmaceutical commercialisation. The program is administered by QUT and supported by our industry leading partners: AbbVie | Amgen | The Australian National University (ANU) | AstraZeneca | Biodesign Australia | CSIRO | Moderna | Pfizer | Roche | UNSW | The University of Western Australia 📓 Access interactive online learning materials at your own pace from anywhere around Australia. 🤝 Connect with industry leaders in the Australian biotech ecosystem. Network with peers at events including the three-day Symposium. 👋 Join an alumni community of over 900 industry professionals. ⭐ Learn from the experts through our seminar series, presented by some of the biggest names in the business. 💡 Pitch your ideas and receive real-world feedback from industry experts in our pitch competition. Winners receive a funded industry immersion experience. QUT (Queensland University of Technology) | QUT Centre for Genomics and Personalised Health #BioTech #commercialisation #training #industry #professionaldevelopment
-
-
Exciting news! 📣 The Bridge Program has extended its application deadline to 9 February 2025. Join one of the country’s most significant biotech professional networks! Access the course flyer: https://lnkd.in/gkHv4VpZ Learn more and apply: https://lnkd.in/gCkdvDh The Bridge Program is a year-long training program on the scientific, legal, financial, clinical, regulatory and reimbursement elements of pharmaceutical commercialisation. The program is administered by QUT and supported by our industry leading partners: AbbVie | Amgen | The Australian National University (ANU) | AstraZeneca | Biodesign Australia | CSIRO | Moderna | Pfizer | Roche | UNSW | The University of Western Australia 📓 Access interactive online learning materials at your own pace from anywhere around Australia. 🤝 Connect with industry leaders in the Australian biotech ecosystem. Network with peers at events including the three-day Symposium. 👋 Join an alumni community of over 900 industry professionals. ⭐ Learn from the experts through our seminar series, presented by some of the biggest names in the business. 💡 Pitch your ideas and receive real-world feedback from industry experts in our pitch competition. Winners receive a funded industry immersion experience. QUT (Queensland University of Technology) | QUT Centre for Genomics and Personalised Health #BioTech #commercialisation #training #industry #professionaldevelopment
-
-
Calling all researchers! Ready to take your work to the next level? Testing hypotheses isn’t just for the lab - it’s essential in the market too. That’s where ON Prime, CSIRO’s transformative innovation program, comes in. Whether you’re exploring new applications for your technology, seeking funding, or preparing for commercialisation, ON Prime (https://lnkd.in/gAWsdk7j) equips you with the tools to: 💡 Validate your ideas with real-world insights 🤝 Discover potential customers and sectors beyond your current focus 🗣️ Master the art of communicating research impact effectively to stakeholders Don’t let your groundbreaking work stay in the lab. Take the first step toward real-world impact. Find out more: https://lnkd.in/gq5b6FTp Applications for ON Prime are open now! Apply today: https://lnkd.in/gAd2agF
-
-
The Bridge Program has extended its application deadline to 9 February 2025. If you're a mid-career drug development or biotech professional looking to expand your commercialisation knowledge and networks, now's your chance! Apply now and join a nationwide biotech network! Link: https://lnkd.in/gCkdvDh
-
-
The Bridge Program 2025 applications are now open! 🌟 Your pathway to pharmaceutical and biotech commercialisation starts here 👇 Access the course flyer: https://lnkd.in/gkHv4VpZ Learn more and apply: https://lnkd.in/gCkdvDh Connect with industry leaders in the Australian biotech ecosystem and join an alumni community of over 900 industry professionals. Take part in face-to-face and online training in the scientific, legal, financial, clinical, regulatory and reimbursement elements of pharmaceutical commercialisation. Applications Close: January 31, 2025 QUT (Queensland University of Technology) #BridgeProgram2025 #CareerDevelopment #BioTech
-
-
Join one of the country’s most significant biotech professional networks! Applications for the Bridge Program 2025 close Jan 31 ⏳ Access the course flyer: https://lnkd.in/gkHv4VpZ Learn more and apply: https://lnkd.in/gCkdvDh Delivered by QUT (Queensland University of Technology) and our consortium of industry and university partners, the Bridge Program is a year-long training program on the scientific, legal, financial, clinical, regulatory and reimbursement elements of pharmaceutical commercialisation. 📓 Access interactive online learning materials at your own pace from anywhere around Australia. 🤝 Connect with industry leaders in the Australian biotech ecosystem. Network with peers at events including the three-day Symposium. 👋 Join an alumni community of over 900 industry professionals. ⭐ Learn from the experts through our seminar series, presented by some of the biggest names in the business. 💡 Pitch your ideas and receive real-world feedback from industry experts in our pitch competition. Winners receive a funded industry immersion experience. #BioTech #commercialisation #training #industry #professionaldevelopment
-
-
The Bridge Program reposted this
Proud to have successfully completed The Bridge Program delivered by QUT (Queensland University of Technology) 🎉 ! This program has been an invaluable experience, enhancing my understanding of pharmaceutical research commercialisation, from intellectual property management to navigating regulatory pathways and market strategies. A big thank you to the outstanding mentors, industry leaders, and fellow participants for sharing their knowledge and to Griffith Hack for supporting my efforts in achieving this milestone. The insights and connections gained through this program will undoubtedly strengthen my ability to support innovation in the pharmaceutical and biotechnology sectors. Looking forward to leveraging these learnings to drive impactful collaborations and projects in the future! 🚀 #TheBridgeProgram #PharmaceuticalResearch #Commercialization #Commercialisation #Innovation #ProfessionalDevelopment #IntellectualProperty
-
The Bridge Program reposted this
Closing event of The Bridge Program along with our graduation. Great learning on commercialisation of our bench on research.
-
-
The Bridge Program reposted this
The Bridge Program closing event marks our graduation from this amazing yearly program where we learnt the pathways of bringing the research benefits to the end users that are in need of a medical treatment.
-